A recent editorial published jointly by JBJS, CORR and BJJ has established a new set of guidelines for the publication of randomized clinical trials [
1]. The purpose of these guidelines is clearly and explicitly set out in the editorial and one cannot argue with the intent. As pointed out in the editorial biased acceptance by journals of positive outcome trials versus neutral or negative outcome trials may lead to an incorrect interpretation of data. By requiring registration of all randomized clinical trials in a public repository of clinical trials all results must be available thus avoiding unnecessary duplication and providing a more balanced picture when performing literature searches or meta-analyses. …